94 results on '"Gattorno, M"'
Search Results
2. POS1372 THE 2021 EULAR AND ACR POINTS TO CONSIDER FOR DIAGNOSIS, MANAGEMENT AND MONITORING OF THE IL 1 MEDIATED AUTOINFLAMMATORY DISEASES: CAPS, TRAPS, MKD, AND DIRA
3. POS1305 PEDIATRIC SAPHO SYNDROME: SINGLE ENTITY OR COMBINATION OF DIFFERENT DISEASES?
4. POS1330 SAFETY OF ANAKINRA IN PATIENTS WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES (CAPS) USING A GRADUATED PRE-FILLED SYRINGE
5. FRI0482 A SYSTEMATIC REVIEW FOR THE MANAGEMENT OF THE GENETICALLY DEFINED IL-1-MEDIATED AUTOINFLAMMATORY DISEASES, CAPS, TRAPS, MKD AND DIRA
6. THU0047 THE SYNOVIUM REWIRES AN IMMUNOLOGICAL RHEOSTAT THAT DEFINES TWO FUNCTIONALLY DISPARATE PATHOGENIC CD4+HLA-DR+ SUBSETS IN HUMAN ARTHRITIS
7. OP0293 USE OF WHOLE-BODY MAGNETIC RESONANCE TO IDENTIFY POTENTIAL DIAGNOSTIC CLUES IN CHILDREN WITH FEVER OF UNKNOWN ORIGIN (FUO)
8. THU0501 EARLY DIAGNOSIS OF THE AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) IN PATIENTS WITH UNDEFINED AUTOINFLAMMATORY OR AUTOIMMUNE DISORDERS: THE PRACTICAL ROLE OF A FLOW CYTOMETRY PANEL
9. OP0273 ADHERENCE TO COLCHICINE TREATMENT AND COLCHICINE RESISTANCE IN A MULTICENTRIC FMF NATIONAL COHORT
10. FRI0457 LONG-TERM OUTCOMES AND TREATMENT EFFICACY IN PATIENTS WITH TNF RECEPTOR-ASSOCIATED AUTOINFLAMMATORY SYNDROME (TRAPS) FROM THE EUROFEVER INTERNATIONAL REGISTRY
11. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry
12. FRI0488 A Phase Iii Pivotal Umbrella Trial of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes (Colchicine Resistant FMF, HIDS/MKD and TRAPS)
13. THU0569 Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes (Colchicine Resistant FMF, HIDS/MKD and TRAPS)
14. FRI0489 Canakinumab Improves Patient Reported Outcomes in Patients with Periodic Fever Syndromes: Table 1.
15. OP0193 Pyrin and PSTPIP1, Mutated in FMF, PAPA-, and PAMI Syndrome, are Involved in the Hypersecretion of Alarmins MRP8/14
16. SAT0001 Cryopyrin Associated Periodic Syndromes (CAPS): Investigations on Knock-In Mouse Model to Exploit Novel Approaches for the Modulation of the NLRP3 Inflammasome
17. FRI0526 Long-Term Efficacy of IL-1 Blockers in Papa Patients: Table 1
18. AB0644 B Cell Characterization in ADA2 Deficiency Patients
19. SAT0484 Prevalence of Cecr1 Mutations in Pediatric Patients with Polyarteritis Nodosa, Livedo Reticularis and/or Stroke
20. AB1014 Enlarging the Clinical Spectrum of Sting-Associated Vasculopathy with Onset in Infancy (SAVI)
21. OP0195 Enhanced NLRP3-Dependent Interleukin-1B Secretion Correlates with Disease Activity in Pyogenic Sterile Arthritis Pyoderma Gangrenosum and Severe ACNE (PAPA) Syndrome
22. OP0007 Blood Interferon Signature as a Screening For Type I Interferonopathies in Children With Early-Onset SLE and Vasculopathy
23. SP0015 Impact on NGS in Daily Practice in Autoinflammatory Diseases
24. FRI0335 The Eurofever Project: Towards the Longitudinal Stage
25. SAT0504 How Experts on Autoinflammatory Diseases Classify Inherited Periodic Fevers and Pfapa: Preliminary Results of the Eurofever Delphi Survey
26. SAT0532 Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF-Receptor Associated Periodic Syndrome (TRAPS)
27. THU0528 Severe Erytrodermic Psoriasis and Arthritis as Clinical Presentation of a Card14-Mediated Pustular Psoriasis (CAMPS)
28. OP0128 The Regulation of MRP8/14 in Pstpip1-Associated Myeloid-Related-Proteinaemia Inflammatory Syndrome (PAMI)
29. THU0482 Gene Expression Profiling of Whole Blood Samples of TRAPS Patients Shows Insight into the Molecular Pathogenesis of TRAPS and Response to Canakinumab Treatment
30. OP0280 Recurrent Pericarditis in Children and Adolescents: A Large, Multicentric Case-Series and Implications for the Pediatric Rheumatologist
31. SP0072 Lessons Learned from the Eurofever Project
32. FRI0332 Evaluation of treatment in PFAPA syndrome: International cohort and literature review
33. FRI0026 Evidence for interleukin (IL)-1β pathway activation in monocytes from patients with familial mediterranean fever (fmf) and pyogenic sterile arthritis, pyoderma gangrenosum and acne (papa) syndrome
34. AB1201 Diversity in clinical manifestations of autoinflammatory syndromes in a french paediatric rheumatology referral center
35. AB1179 Failure of adalimumab treatment in three patients with papa syndrome
36. OP0107 Clinical features at presentation in a series of 86 patients with genetically confirmed traps and 33 patients with inflammatory symptoms and the r92q variant from the eurofevers/eurotraps registry
37. THU0334 Differences in the features of familial mediterranean fever among patients from europe as compared to those from the eastern mediterranean countries
38. FRI0346 PED-BD, cohort study for paediatric behÇet’s disease: Update 2012 reporting 206 patients
39. SP0156 What’s new in clinical management of autoinflammatory diseases
40. AB1191 Within-patient analysis during anakinra and canakinumab treatment in cryopyrin associated periodic syndrome
41. THU0396 Efficacy and safety of canakinumab in patients with TNF receptor associated periodic syndrome (TRAPS)
42. OP0138 B cell subsets phenotype in autoimmunity with immunodeficiency: Analysis of a large cohort of patients with apeced syndrome
43. OP0175 The eurofever registry for autoinflammatory disease: Update on enrollment after 2 years
44. SAT0466 PED-BD COHORT 2013: Expert Consensus Classification Gives Higher Sensitivity than the International Study Group Criteria to Define Behcet’s Disease in Children
45. Guidelines for the genetic diagnosis of hereditary recurrent fevers
46. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
47. Serum interleukin 12 concentration in juvenile chronic arthritis
48. The Antiphospholipid Syndrome.
49. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
50. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.